. ANGPTL7 regulates the expansion and repopulation of human hematopoietic stem and progenitor cells.
Introduction
Hematopoietic stem cells (HSCs), which are commonly used for HSC transplantation in patients with cancer or hematopoietic disorders, are capable of self-renewal and differentiation into all blood cell types 1, 2 . In mammals, both intracellular and extracellular signals contribute to the homeostasis of HSCs 3-6 , but the mechanisms involved in the control of HSCs fates are still poorly understood.
Numerous attempts have been made to increase the long-term maintenance of HSCs in culture. Stromal cell lines derived from brain endothelial cells 7 , aorta-gonads-mesonephros 8 , and fetal liver hepatic progenitors 9 have been established and evaluated to expand HSCs ex vivo, as stromal cells can not only secrete growth factors 10 but mimic the HSC niche, which controls the balance between HSC self-renewal and differentiation 11, 12 .
Several growth factors associated with HSC self-renewal and expansion have been identified. Treatment of mouse bone marrow HSCs with pleiotrophin (PTN) 13 or Angptl family 14, 15 , especially Angptl 2 and Angptl 3, caused a marked increase in long-term repopulating HSC counts in culture and ex vivo. Growth factors like EGF-EGFR signaling regulates HSC regeneration after radiation injury 16 . In addition, multiple reports have shown that the Wnt signaling pathway plays a key role in regulating HSC self-renewal 17, 14 and maintenance. In mice, activation of the canonical Wnt signaling through β-catenin overexpression 18 or the treatment of cells with glycogen synthase kinase 3 (GSK-3) inhibitors 19 , which indirectly activate β-catenin, preserve HSC stemness. The study of signaling pathway that modulates HSC stemness is important for understanding the basic biology of HSC and will provide critical insight into their clinical applications.
ANGPTLs belong to a 7-member family of secreted glycoproteins that share 80% sequence homology with mouse Angptls. Each ANGPTL contains an N-terminal coiled-coil domain and a C-terminal fibrinogen-like domain. It is known that several members of the ANGPTL family play roles in regulating lipid metabolism and angiogenesis 20 . ANGPTL proteins are also involved in the construction of extracellular matrix (ECM) formation, thus they are potential therapeutic targets for metabolic syndrome and cardiovascular disease 21, 22 . In particular, ANGPTL7 in the ECM of the trabecular meshwork plays an important role in the deposition and organization of the matrix of the outflow tissue 21 . Recently, several studies suggested that Angptls play roles in the regulation of HSC activity. Recently, Angptl3, Angptl5
and Angptl7 stimulate mouse HSC expansion ex vivo 14, 23 . Although Angptl5 substantially promotes the expansion of human HSCs in vitro and ex vivo 24 , it remains inconclusive whether ANGPTL7 is also able to promote the expansion of human HSCs and the downstream signaling cascade activated by ANGPTL7 in HSCs has not been well characterized.
In this study, we found that a stromal cell line established from mouse fetal liver expressed high levels of Angptl7 and promoted human HSPC expansion in cell culture condition. We demonstrated that recombinant ANGPTL7 increased the engraftment capacity of human HSPCs in a xenograft mouse model and ANGPTL7-stimulated human HSPC expansion depended on Wnt signal pathway.
7 unless otherwise noted. The WBCs were counted with a hemocytometer and analyzed by flow cytometry every 3 days. Human UCB CD34+ cells were enriched via magnetic cell sorting (Miltenyi, Bergisch Gladbach, Germany) and were seeded into the wells of a U-bottom 96-well plate. StemSpan serum-free medium was used as the basal medium. The basal medium supplemented with 100 ng/mL of human SCF (Peprotech, Rochy Hill, USA), 20 ng/mL of TPO (Peprotech, Rochy Hill, USA), 100 ng/mL of mouse PTN (Peprotech, Rochy Hill, USA), and 50 ng/mL human FLT3L
(Peprotech, Rochy Hill, USA) was used as STPF medium. The STPF medium supplemented with 500ng/mL ANGPTL7 was named as ASTPF medium. Wnt3a
(R&D, Minneapolis, MN, USA) protein was used at 100 
NSI assay for ex vivo expanded CB HSCs
A total of 1×10 4 uncultured human umbilical cord blood (UCB) CD34+ cells or the progeny of 1×10 4 human UCB CD34+ cultured in STPF (SCF, TPO, PTN, and FLT3L) or ASTPF (ANGPTL7, SCF, TPO, PTN, and FLT3L) medium for 7 days were pooled together and injected intravenously via the retro-orbital route into sublethally irradiated (1.5 Gy) 8-to 10-week-old NSI mice. After 8 to 12 weeks, mice were sacrificed, and PBMC, splenocytes, and BM cells were analyzed by flow cytometry for the presence of human CD45+ cells. In our engraftment assay, the mice were considered to have engrafted successfully if we detected ≥ 0.1% human CD45+ cells in the bone marrow at 8 weeks after transplant. For limiting-dilution analysis, mice were considered positive for human HSC engraftment when at least 1% CD45+
human cells were detected among the mouse bone marrow cells at 8 weeks after transplant, unless otherwise indicated.
Homing assay
Sub-lethally irradiated NSI mice (10 Gy) were either transplanted with human CD34+ cells (1×10 6 /mouse) without culture or cultured in STPF medium or ASTPF medium for 7 days. Where indicated, part of the progeny of 1×10 6 CD34+ cells in ASTPF condition were incubated prior to injection with 10 ug/10 6 cells of anti-human CXCR4 mAb (clone 12G5; ebioscience, San Diego, CA, USA). 16 hours posttransplantation, BM and spleen were analyzed for the presence of human CD34+ cell.
Image acquisition
Images were acquired on a Leika DMI6000B fluorescence microscope using 20× objective lens. Images of PL08 cells in RPMI-1640 culture media were acquired at room temperature by DFC digital camera using Leika FW4000 version 1.2.1 software. performed to detect the ANGPTL7 protein using the Rabbit ANGPTL7-specific antibody (ab118198, Abcam, Cambridge, UK) and the Rabbit 6×His tag-specific antibody (ab1187, Abcam, Cambridge, UK). We sent the purified protein for mass spectrometry analysis for protein identification.
Colony-forming cell (CFC) assays

Gene expression analysis
The sequencing reads were mapped to the mouse RefSeq-RNA reference sequence (downloaded from http://hgdownload.cse.ucsc.edu/downloads) using the 
Statistical analysis
Data were analyzed using GraphPad Prism 4 with Student's t-test. P values less than 0.05 were considered statistically significant.
Results
Stromal cell clone PL08 supports human HSPC expansion in vitro
Fetal liver HSCs undergo dramatic expansion during embryonic development 27 .
Thus, we hypothesized that certain stromal cells in the fetal liver might secrete proteins to promote HSCs proliferation. In an attempt to establish immortalized fetal liver cell lines, we isolated primary stromal cells from livers of mouse embryos at 11.5 days of gestation (dpc) and immortalized them by transduction with SV40 large T antigen. Twenty clones (named PL01-PL20) were established after 8 weeks. Out of these twenty clones, PL01 and PL08, both of which were adherent and grew robustly Figure 3) , indicating that the results of the RNA-seq analysis were reliable for further analysis.
Hierarchical clustering analysis showed that 77 genes encoding secreted proteins, including Angptl7, Ptn, Bmp4, and Wnt10b were highly expressed in PL08 cells but not in PL01 cells ( Figure 2B ). Ptn, which is a growth factor supporting the expansion of HSCs 13 , was highly expressed in both PL08 and Mito-treated PL08 cells Figures 6-8 ). The percentages and the total number of Lin-CD34+CD38-human HSPCs were both significantly lower in Angptl7-null PL08 hanging-culture conditions than in normal PL08 co-culture conditions after 12 days culture ( Figure 2D-E) . In accordance, hUCBNCs co-cultured with Angptl7-null PL08 cells for seven days resulted in a significant reduction in total CFC content and a decrease in GEMM colony-generating cells compared to that cultured in normal PL08 cells ( Figure 2F ).
Thus, the results suggested that the loss of Angptl7 made PL08 fail to support human HSPC expansion in culture.
ANGPTL7 stimulates human HSPC expansion in vitro
To understand whether recombinant ANGPTL7 promotes human HSPC expansion, we constructed a plasmid containing the entire coding sequence of 
ANGPTL7 stimulates the ex vivo expansion of human HSPCs
To examine whether ANGPTL7 treatment increases the engraftment capacity of Table 2 ). Taken together, these results suggested that ANGPTL7
enhanced the ex vivo expansion of human HSPCs but not alter HSPC differentiation capacities.
ANGPTL7-stimulated HSPC expansion is dependent on Wnt signaling
To dissect the mechanisms through which ANGPTL7 regulates HSPC expansion, we conducted RNA-seq analysis to profile the global gene expression of ANGPTL7-treated human HSPCs and ANGPTL7-untreated HSPCs ( Figure 5A ). We identified 330 genes with at least two-fold expression changes upon ANGPTL7 stimulation (Supplementary Table 3 ). Ingenuity pathway analysis showed that the Wnt signaling that regulates hematopoiesis 33-35 was activated in ANGPTL7-treated HSPCs (
Figure 5B). We confirmed the results of the RNA-seq analysis by qRT-PCR ( Figure   5C ). Figure 5C ).
We thus validated whether ANGPTL7 treatment promoted homing by injecting ANGPTL7-traeted and ANGPTL7-untreated HSPCs into sub-lethally irradiated NSI mice. 16 hours after transplantation, we found that the percentages of human CD34+ cells in both BM and spleens of mice that were transferred with ANGPTL7-stimulated
HSPCs were higher than that in other control groups ( Figure 5D ), suggesting that ANGPTL7 enhanced HSC homing, which was consistent with increased CXCR4
expression. In addition, the expression of HOXB4 that was important for HSC self-renewal 44 was also augmented after ANGPTL7 treatment. However, ANGPTL7
treatment did not alter the expression of LAIR1 or LILRB2 that were both reported to be the receptors of ANGPTL7 in HSCs 15 ( Figure 5C ).
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